Literature DB >> 20206177

Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

Veerle Bieghs1, Kristiaan Wouters, Patrick J van Gorp, Marion J J Gijbels, Menno P J de Winther, Christoph J Binder, Dieter Lütjohann, Maria Febbraio, Kathryn J Moore, Marc van Bilsen, Marten H Hofker, Ronit Shiri-Sverdlov.   

Abstract

BACKGROUND & AIMS: Nonalcoholic steatohepatitis (NASH) is a disorder that consists of steatosis and hepatic inflammation. It is not known why only some people with steatosis develop NASH. Recently, we identified dietary cholesterol as a factor that directly leads to hepatic inflammation and hepatic foam cell formation. We propose a mechanism by which Kupffer cells (KCs) take up modified cholesterol-rich lipoproteins via scavenger receptors (SRs). KCs thereby accumulate cholesterol, become activated, and may then trigger an inflammatory reaction. Scavenging of modified lipoproteins mainly depends on CD36 and macrophage scavenger receptor 1.
METHODS: To evaluate the involvement of SR-mediated uptake of modified lipoproteins by KCs in the development of diet-induced NASH, female low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice were lethally irradiated and transplanted with bone marrow from Msr1(+/+)/Cd36(+/+)or Msr1(-/-)/Cd36(-/-) mice and fed a Western diet.
RESULTS: Macrophage and neutrophil infiltration revealed that hepatic inflammation was substantially reduced by approximately 30% in Msr1(-/-)/Cd36(-/-)-transplanted mice compared with control mice. Consistent with this, the expression levels of well-known inflammatory mediators were reduced. Apoptotis and fibrosis were less pronounced in Msr1(-/-)/Cd36(-/-)-transplanted mice, in addition to the protective phenotype of natural antibodies against oxidized low-density lipoprotein in the plasma. Surprisingly, the effect on hepatic inflammation was independent of foam cell formation.
CONCLUSIONS: Targeted inactivation of SR pathways reduces the hepatic inflammation and tissue destruction associated with NASH, independent of hepatic foam cell formation. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206177      PMCID: PMC3114629          DOI: 10.1053/j.gastro.2010.02.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

Review 1.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.

Authors:  Vidya V Kunjathoor; Maria Febbraio; Eugene A Podrez; Kathryn J Moore; Lorna Andersson; Stephanie Koehn; Jeongmi S Rhee; Roy Silverstein; Henry F Hoff; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

3.  Antibodies to oxidized LDL in relation to carotid atherosclerosis, cell adhesion molecules, and phospholipase A(2).

Authors:  J Hulthe; O Wiklund; E Hurt-Camejo; G Bondjers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-02       Impact factor: 8.311

4.  Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta.

Authors:  P Gervois; N Vu-Dac; R Kleemann; M Kockx; G Dubois; B Laine; V Kosykh; J C Fruchart; T Kooistra; B Staels
Journal:  J Biol Chem       Date:  2001-06-20       Impact factor: 5.157

5.  Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.

Authors:  Kristiaan Wouters; Patrick J van Gorp; Veerle Bieghs; Marion J Gijbels; Hans Duimel; Dieter Lütjohann; Anja Kerksiek; Roger van Kruchten; Nobuyo Maeda; Bart Staels; Marc van Bilsen; Ronit Shiri-Sverdlov; Marten H Hofker
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

6.  Macrophage foam cell formation with native low density lipoprotein.

Authors:  Howard S Kruth; Wei Huang; Itsuko Ishii; Wei-Yang Zhang
Journal:  J Biol Chem       Date:  2002-07-12       Impact factor: 5.157

7.  Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.

Authors:  Jennifer J Manning-Tobin; Kathryn J Moore; Tracie A Seimon; Susan A Bell; Maia Sharuk; Jacqueline I Alvarez-Leite; Menno P J de Winther; Ira Tabas; Mason W Freeman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-10-23       Impact factor: 8.311

Review 8.  Neutrophil-mediated tissue injury in alcoholic hepatitis.

Authors:  Hartmut Jaeschke
Journal:  Alcohol       Date:  2002-05       Impact factor: 2.405

Review 9.  TNF-induced signaling in apoptosis.

Authors:  P C Rath; B B Aggarwal
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.542

10.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

Authors:  Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more
  62 in total

1.  Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.

Authors:  Anisha A Gupte; Joey Z Liu; Yuelan Ren; Laurie J Minze; Jessica R Wiles; Alan R Collins; Christopher J Lyon; Domenico Pratico; Milton J Finegold; Stephen T Wong; Paul Webb; John D Baxter; David D Moore; Willa A Hsueh
Journal:  Hepatology       Date:  2010-10-11       Impact factor: 17.425

2.  OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36.

Authors:  Chenghui Xie; Hangpong Ng; Shanmugam Nagarajan
Journal:  Immunol Lett       Date:  2011-01-31       Impact factor: 3.685

3.  Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.

Authors:  Camella G Wilson; Jennifer L Tran; Derek M Erion; Nicholas B Vera; Maria Febbraio; Ethan J Weiss
Journal:  Endocrinology       Date:  2015-12-09       Impact factor: 4.736

4.  Nonalcoholic fatty liver disease: from lipid profile to treatment.

Authors:  Kouichi Miura; Hirohide Ohnishi
Journal:  Clin J Gastroenterol       Date:  2012-06-17

5.  Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis.

Authors:  Derrick M Van Rooyen; Claire Z Larter; W Geoffrey Haigh; Matthew M Yeh; George Ioannou; Rahul Kuver; Sum P Lee; Narci C Teoh; Geoffrey C Farrell
Journal:  Gastroenterology       Date:  2011-06-23       Impact factor: 22.682

6.  Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids.

Authors:  Aafke W F Janssen; Tom Houben; Saeed Katiraei; Wieneke Dijk; Lily Boutens; Nieke van der Bolt; Zeneng Wang; J Mark Brown; Stanley L Hazen; Stéphane Mandard; Ronit Shiri-Sverdlov; Folkert Kuipers; Ko Willems van Dijk; Jacques Vervoort; Rinke Stienstra; Guido J E J Hooiveld; Sander Kersten
Journal:  J Lipid Res       Date:  2017-05-22       Impact factor: 5.922

7.  Alterations of Cholesterol Metabolism in Inflammation-Induced Atherogenesis.

Authors:  David P Hajjar; Katherine A Hajjar
Journal:  J Enzymol Metab       Date:  2016-05-31

8.  Dietary plant stanol ester supplementation reduces peripheral symptoms in a mouse model of Niemann-Pick type C1 disease.

Authors:  Inês Magro Dos Reis; Tom Houben; Yvonne Oligschläger; Leoni Bücken; Hellen Steinbusch; David Cassiman; Dieter Lütjohann; Marit Westerterp; Jos Prickaerts; Jogchum Plat; Ronit Shiri-Sverdlov
Journal:  J Lipid Res       Date:  2020-04-14       Impact factor: 5.922

9.  Trapping of oxidized LDL in lysosomes of Kupffer cells is a trigger for hepatic inflammation.

Authors:  Veerle Bieghs; Sofie M A Walenbergh; Tim Hendrikx; Patrick J van Gorp; Fons Verheyen; Steven W Olde Damink; Ad A Masclee; Ger H Koek; Marten H Hofker; Christoph J Binder; Ronit Shiri-Sverdlov
Journal:  Liver Int       Date:  2013-04-25       Impact factor: 5.828

10.  Krüppel-like factor 2 promotes liver steatosis through upregulation of CD36.

Authors:  Jin-Lian Chen; Xiao-Jie Lu; Kai-Lin Zou; Kun Ye
Journal:  J Lipid Res       Date:  2013-07-15       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.